Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials

Launched by POWER LIFE SCIENCES INC. · Mar 3, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the experiences of women with Triple Negative Breast Cancer when it comes to participating in medical research. The study aims to uncover the challenges and obstacles that might prevent patients from joining these trials, as well as reasons why some may choose to leave them. By gathering this information, the researchers hope to improve future clinical trials and make it easier for women with this type of breast cancer to participate in research that could benefit their treatment options.

To be eligible to participate, women must be at least 18 years old and able to attend scheduled visits and follow the study's guidelines. They also need to be capable of giving their consent to join the study. However, pregnant or breastfeeding women, as well as those with certain medical or mental health conditions that prevent them from participating, cannot join. Although the trial is not yet recruiting participants, it aims to gather valuable insights that could help improve the experience of future patients in clinical research.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
• • Capable of giving signed informed consent, which includes compliance with requirements and restrictions listed in the informed consent form (ICF) and in the protocol
• Exclusion Criteria:
• • Pregnant or lactating woman
• • Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
• • Inability to perform regular electronic reporting